Effects of Chardonnay Seed Flour on Vascular Health

NCT02093455 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 168

Last updated 2022-02-11

No results posted yet for this study

Summary

This is a randomized, double-blinded trial (Chardonnay seed flour vs. placebo - in pill form) with the purpose to test the impact of a four-month supplementation with Chardonnay Seed Flour (CSF) on endothelial function. Chardonnay flour is made from wine grape skins and seeds. We will examine the effect of CSF on parameters such as endothelial function (via EndoPAT testing), plasma lipid levels, glucose tolerance, insulin resistance, inflammatory markers, oxidative stress surrogates, endothelial progenitor cells (EPCs) as well as the makeup of and impact on the gut microbiome (via stool samples).

Conditions

  • 1. Endothelial Dysfunction (EndoPAT Score <=2)

Interventions

DIETARY_SUPPLEMENT

Chardonnay Seed Flour (CSF)

CSF is made from wine grape skins and seeds.

DIETARY_SUPPLEMENT

Placebo

Sponsors & Collaborators

  • Whole Vine Products

    collaborator UNKNOWN
  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Amir Lerman, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2017-08-23
Completion
2017-08-23

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02093455 on ClinicalTrials.gov